Glomerulosclerosis, Focal Segmental: Clinical Trials

1 trial for Glomerulosclerosis, Focal Segmental, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Glomerulosclerosis, Focal Segmental: new trials by email Literature Review of Glomerulosclerosis, Focal Segmental trials Research Report on Glomerulosclerosis, Focal Segmental

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valproic Acid for Idiopathic Nephrotic Syndrome
Valproic Acid - Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis
Phase 2 / Phase 3UnknownUniversitair Ziekenhuis Brussel152016-10-012017-06-20

Narrower conditions

Nephrosis, Lipoid (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Nephrosis (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Valproic Acid (1)

Sponsors

Universitair Ziekenhuis Brussel (1)

Countries

Belgium (1)

Top investigators

Peter Janssens, MD (1)